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ABSTRACT OF THE DISSERTATION
Anterior Cruciate Ligament Elasticity and Force for Knee Flexion during the Menstrual
Cycle in Oral Contraceptive Users and Non-oral Contraceptive Users

by
Haneul Lee
Doctor of Sciecne, Graduate Program in Physical Therapy
Loma Linda University, June 2013
Dr. Jerrold Petrofsky, Chairperson

Numerous studies have been conducted on changes of knee ligament laxity during
the menstrual cycle (MC) since there are more injuries in certain phases. Some
researchers believe that since estrogen receptor β exists in ligaments and tendons in the
knee, estrogen may modulate towards a state of laxity. However, increased tissue
temperature also observed during the MC can predispose ligament and tendon laxness.
The number of women using oral contraceptive pills (OCP) has constantly
increased in the United States. This exogenous source of synthetic forms of steroid
hormones prevents ovulation by maintaining more consistent daily hormone levels than
occurs. Since the estrogen receptor β exists on human connective tissue, OCP might have
an impact on tendon and ligament synthesis, structure, and biomechanical properties.
Therefore, the purpose of this study was to assess in women the relationship between
Estradiol (E2) serum concentrations and tissue temperature during the MC and their
combined effect on ACL elasticity, force to flex the knee (FFK), and knee flexionextension hysteresis (KFEH) in OCP users and non-OCP users.

xii

Nineteen non-athletic young healthy females were divided into two groups; OCP users
and non-OCP users. E2 serum concentrations, ACL elasticity, FFK, and KFEH were
assessed both at ambient temperature (22 °C) and after 38 °C warming of the leg to
stabilize the normal temperature during the MC.
The result of this investigation showed that ACL elasticity was significantly lower
and FFK and KFEH were significantly higher during ovulation compared to menstruation
(p<0.05) but after 38 °C warming of the leg, there were no differences in KKF and KFEH
in non-OCP users. Also, ACL elasticity was significantly lower and FFK and KFEH were
significantly higher OCP users than non-OCP users (p<0.05) at ambient temperature. But,
no significant difference in FFK and FFEH between the two groups was found after
warming to 38 °C.
In conclusion, OCP users have more knee stiffness and effect of heat on FFK
and KFEH when their legs were heated compared to non-OCP users. In addition,
ACL elasticity, FFK, and KFEH were affected not only by estrogen but tissue
temperature during the menstrual cycle.
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CHAPTER ONE
INTRODUCTION

Knee injuries occur most frequently in the anterior cruciate ligament (ACL); 80%
of ACL injuries are non-contract ACL injuries 1. Due to an increase in women’s sports
participation, many researchers have looked at injuries occurring during sports activities
and found that ACL injuries are more common in women compared to men who
participate in the same activities 2-5. The differences are commonly assumed to be
differences in the anatomical, neuromuscular, behavior patterns, and hormones that make
women more susceptible to ACL injuries than men 6,7. Regarding hormonal influences,
many previous investigators have examined the relationship between female reproductive
hormones and structure and mechanical properties of the ACL 8-11. The role of estrogen
in possibly causing ACL injuries has recently been studied at the celluar level and the
presence of 17- beta estradiiol receptors in the human ACL and muscle have been
investigated 10-13. The constant changes in estrogen concentration in blood during the
menstrual cycle have been investigated to see if sex hormones are related to ligament
laxity 10-13. Human tendon, muscle, and ligament are composed of collagen fibers closely
packed together. Due to the decrease of collagen formation and fibroblast proliferation
with an increased estrogen serum concentration, the decreased collagen synthesis is
believed to cause ligament laxness, and muscle and tendon flexibility all of which makes
the ACL more susceptible to injuries 8, 10, 12.
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Estradiol is the estrogen in women that is most commonly measured in young
non-pregnant females 14. Since most ACL injuries occur in young healthy women, most
investigators have used estradiol as the major estrogen biomarker. Estrodial serum
concentration fluctuates throughout the menstrual cycle but in women who are taking oral
contraceptive pills (OCP), it does not vary during the menstrual cycle 15,16. Eighty two
percent of sexually active women aged 15-44 have used the OCP in the United States and
14% of women have used OCP for non-contraceptive purposes such as cycle regulation,
treatment of dysmenorrhea and amenorrhea 17,18. OCP consists of combined estrogen and
progesterone as synthetic steroids and it plays a role in suppressing pituitary FSH and LH
production and preventing ovulation from occurring 18,19. This exogenous source of
synthetic forms of the hormone prevents ovulation by maintaining more constant
hormone levels 20. Since estrogen is stabilized throughout the entire menstrual cycle, the
response may be different in women on OPC. Therefore, OCP may be another factor that
affect on tendon and ligament synthesis, structure, and biomechanical properties.
Martineau and colleagues have shown that OCP usesrs have less ACL laxity than nonOCP users 21.
However, there has been controversy as to the ACL laxity changes across the
menstrual cycle. A systemic review on the effects of the menstrual cycle on anterior knee
laxity by Zazulak and colleague showed that only three of the nine studies reported a
significant difference on ACL laxity during the menstrual cycle 22. Among 3 studies
saying there was a significant difference in ACL elasticity during the menstrual cycle, the
results are different. Heitz and colleague showed that there was a greater knee laxity in
the ovulation while Shultz and colleague found a greater knee laxity in the early follicular
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phase 23,24. Although Zazulak and colleague found limited evidence of the correlation
between ACL laxity and sex hormones, they claimed that cycle phases might have an
effect on anterior knee laxity. These researchers suggested that future investigators
should consider the limitation in present methodologies that they had discovered 22. They
also point out confounding variables that might affect anterior knee elasticity during the
menstrual cycle.
Temperature is one of the factors that affect elasticity in connective tissues, such
that, an increase in tissue temperature, by doing warm-up exercises will increase muscle
and tendon extensibility 25, 26. In healthy young adults, normal core temperature is
maintained between 36-37.5°C and it changes approximately 0.5°C throughout the day 27,
28

. In women with a regular menstrual cycle, their core temperature fluctuates not only

throughout the day but also during the menstrual cycle 29. It is at a peak during the
middle luteal phases while in the early follicular and the ovulation it is relatively low 29-31.
However, skin temperature of the arms and legs is commonly measured around 6°C
below the core, 30-31.5°C since human legs and arm tissues are used as a radiator to
remove excess heat from the core 32,33. Due to the core temperature changes throughout
the menstrual cycle, skin temperature can also be altered because of the core temperature
changes. To increase core temperature, arm and leg temperature is reduced at first to
conserve heat 34. To lower core temperature, arm and leg temperature increases to
dissipate heat. Since, ligament, muscle, and tendon extensibility will decrease and
increase with decreased or increased tissue temperature, it is of no surprise that the
menstrual cycle has dramatic effects on tissue extensibility. Although tissue extensibility
decreases with decreased tissue temperature, many studies have reported that anterior
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knee laxity is greater in the ovulation phases where the core temperature is comparatively
lower than other phases 23, 35. However, core temperature increases after ovulation. To
keep core temperature lower at ovulation, the shell must be dissipating more heat to keep
the core cooler 29. Therefore, the shell must be warmer after ovulation. Thus ligament
elasticity change during the menstrual cycle may be a consequence of estrogen
fluctuations alone during the menstrual cycle. However, since sex hormones do not
change in OCP users, their core temperature may change little during the menstrual cycle.
In addition, Rogers and Baker have shown that OCP users have higher core temperature
compared to non-OCP users due to exogenous forms of progesterone in OCP’s 36. Thus,
the effect of estrogen on ACL elasticity and muscle and tendon flexibility is probably a
complex interaction between hormones and tissue temperature.
Many previous researchers examined biomechanical variables related to knee
mechanical properties throughout the menstrual cycle 24, 37, 38. The effect of the menstrual
cycle on knee flexibility measured by force to flex the knee (FFK) and knee flexionextension hysteresis (KFEH) has not been investigated. Restricted knee extension
affects normal leg movement and this could lead to more non-contact ACL injuries 39.
The quadriceps muscle is one of the knee extensor muscles, which is crucial to stabilize
and create range of motion of the knee 40. KFEH is the difference between the FFK and
force to extend the knee (FEK). Elastic energy is stored during loading the knee (flexion)
and is released during unloading (extension); thus, flexing the knee requires greater force
than extending the knee. It represents stored elastic energy in the muscles and tendons,
and lower elastic hysteresis values indicate more elasticity of muscle and tendon 41.
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Therefore, we will interpret quadriceps muscle and tendon flexibility by measuring FFK
and KFEH.
In the present study, two series of experiments were conducted to examine the
relationship ACL elasticity, FFK, and KFEH during the menstrual cycle. In series 1
(Chapter 2), we examined the relationship between estradiol serum concentration and
ACL elasticity, FFK, and KFEH and how this relates to tissue temperature in young
healthy women with a regular menstrual cycle. In series 2 (Chapter 3), we investigated
the differences in ACL elasticity, FFK and KFEH between OCP users and non-OCP
users and its relationship to tissue temperature during the menstrual cycle.
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CHAPTER TWO
ANTERIOR CRUCIATE LIGAMENT ELASTICITY AND FORCE FOR KNEE
FLEXION DURING THE MENSTRUAL CYCLE

Haneul Lee, DSc
Jerrold Petrofsky, PhD
Noha Daher, DrPH
Lee Berk, DrPH
Michale Laymon, DSc
Iman Akef Khowailed, MS

Dept. of Physical Therapy, School of Allied Health Professions
Loma Linda University, Loma Linda, California, USA
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Abstract
Background – A high occurrence of knee injuries have been observed in women
during the menstrual cycle (MC). As a result, numerous studies have been conducted
regarding knee ligament elasticity during the MC. Some researchers believe that since
estrogen receptor β exists in ligaments and tendons in the knee, estrogen may modulate
towards a state of laxity. However, increased tissue temperature also observed during the
MC can predispose ligament and tendon laxness. Therefore, the purpose of this study was
to assess in women the relationship between Estradiol (E2) serum concentrations and
tissue temperature during the MC and their combined effect on knee laxity.
Material and Methods– Ten non-athletic young healthy females, 18 to 30 years of
age participated in the study. E2 serum concentrations, anterior cruciate ligament (ACL)
elasticity, and force to flex the knee (FFK), knee flexion-extension hysteresis (KFEH)
were assessed both at ambient temperature (22 °C) and after 38 °C warming. Testing
was performed multiple times during the participant’s MC, for one full MC.
Results: ACL elasticity was significantly higher (P<0.01) and FFK and KFEH
were significantly lower (p<0.05) during ovulation when E2 levels were highest. ACL
elasticity was still higher during ovulation after warming to 38 °C. But, the effects of MC
on FFK and KFEH were reduced by tissue warming.
Conclusions: ACL elasticity, FFK, and KFEH was affected not only by E2 but
also tissue temperature. However, E2 had more impact on ACL elasticity while tissue
temperature had more impact on FFK and KFEH at 38 °C warming.

Key words: menstrual cycle, ACL elasticity, muscle and tendon flexibility, temperature
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Introduction
In the adult population, numbers of knee injuries arise every year during sports
activities and exercise 1. The most common injuries are ligament sprains, muscle strains,
and contusions 2. In the annually recorded 150,000 injuries affecting the knee, the
Anterior Cruciate Ligament (ACL) injuries are the most frequently occurring injury.
According to the Sports Medicine Media Guide for 2011, the cost of ACL injuries
has been estimated at half a billion dollar annually. Additionally, people who have a
history of ACL injury are at a higher risk of potential arthritis later in their life and will
cost an additional millions of dollars 3. Previous studies have indicated that women have
a 2 to 8 times higher risk factor of knee injuries than men, specifically, involving the
ACL 4-8. There has been ongoing debate on why women are more susceptible.
The differences are commonly assumed to be difference by anatomical,
neuromuscular, behavior patterns, and hormonal influences that make women more
susceptible to ACL injuries 8, 9. Recently investigators have examined the association
between female reproductive hormones and structure material and mechanical properties
of the ACL. There has been a common theory of the presence of 17-beta estradiol
receptor in ACL for decades. The constant changes in the levels of estrogen during the
menstrual cycle have been investigated to see if sex hormones are related to ligament
laxity 10-13. Human tendon, muscle, and ligament are composed of collagen fibers closely
packed together. Due to the decrease of collagen formation and fibroblast proliferation
with an increased estrogen serum concentration, the decreased collagen synthesis causes
ligament looseness, weak muscle strength and tendon elasticity all of which makes the
ACL more susceptible to injuries 10, 11, 14. Estradiol is one of the estrogens in women and
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is the most commonly measured estrogen in young non-pregnant females 15. Since most
ACL injuries occur in young healthy women, most investigators have used estradiol as
the major estrogen biomarker.
However, there has been controversy on the result of ACL laxity changes across
the menstrual cycle. A systemic review on the effects of the menstrual cycle on anterior
knee laxity by Zazulak and colleague showed that only three of the nine studies reported
a significant difference on ACL laxity during the menstrual cycle 6. Although this study
found limited evidence of the correlation between ACL laxity and sex hormones, Zazulak
and colleague claimed that cycle phases might have an effect on anterior knee laxity.
These researchers suggested that future investigators should consider the limitation in
present methodologies that they had discovered 6. They also point out confounding
variables that might affect anterior knee elasticity during the menstrual cycle.
Temperature is one of the factors that affect elasticity in muscles, such that, an
increase in tissue temperature by doing a warm-up exercise will increase muscle and
tendon extensibility 16, 17. Normal core temperature is maintained between 36-37.5°C 18, 19.
The core temperature shows a fluctuation across the menstrual cycle; it is at a peak
during the middle luteal phases while in the early follicular and the ovulation it is
relatively low 20-22. Skin temperature of the arms and legs is commonly measured around
6°C below the core, 30-31.5°C since human legs and arms tissues are used as a radiator
to remove excess heat from the core 23, 24. Due to the core temperature changes
throughout the menstrual cycle, skin temperature can also be altered because of the core
temperature changes. To increase core temperature, arm and leg temperature is reduced at
first to conserve heat. To lower core temperature, arm and leg temperature increases to
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dissipate heat 25. Since, ligament, muscle, and tendon extensibility will decrease and
increase with decreased or increased tissue temperature, it is of no surprise that the
menstrual cycle has dramatic effects on tissue extensibility. Although tissue extensibility
decreases with decreased tissue temperature, many studies have reported that anterior
knee laxity is greater in the ovulation phases where the core temperature is comparatively
lower than other phases 26, 27. However, core temperature increases after ovulation. To
keep core temperature lower at ovulation, the shell must be dissipating more heat to keep
the core cooler 21. Therefore, shell must be warmer after ovulation. These findings may
explain that anterior knee laxity changes are a consequence of estrogen fluctuations alone
during the menstrual cycle. The reported change may be temperature related to and not a
direct effect of estradiol. Thus, the aim of the present study is to examine the relationship
between estradiol serum concentration and ACL elasticity, knee flexibility and how this
relates to tissue temperature in young healthy women with a regular menstrual cycle.

Materials and Methods
Participants
Ten non-athletic young healthy females with a regular menstrual cycle
participated in this study. They were recruited by word of mouth and selected by their
self-reported menstrual cycle. Participants were 18 to 30 years of age with a body mass
index (BMI) between 15 and 30 who had a regular menstrual cycle for at least one year
(Table 1). Participants had no history of pregnancy, neuropathy, myopathy or knee injury,
and were not taking any medication that could alter sex hormones. The study was
approved by Institutional Review Board of Loma Linda University and all participants
signed an informed consent.
10

Table1. Mean (SD) of General characteristic in women with a regular menstrual cycle
(N=10)

Mean (SD)

Age (years)

Height (cm)

Weight (kg)

BMI

Cycle length (d)

24.7 (2.0)

164.6 (3.4)

57.1 (5.0)

21.0 (1.3)

29.5 (3.2)

Abbreviations: SD, standard deviation

Methods
Trained researchers measured all outcome variables throughout the experiments.
The outcome variables assessed were ACL elasticity, force to flex the knee (FFK), knee
flexion-extension hysteresis (KFEH), leg skin temperature, and estradiol serum
concentration.

Estradiol Serum Concentration
Two certified phlebotomists drew 4cc of venous blood samples from each
participant’s antecubital area with 23-guage needles to determine estradiol serum
concentration. The serum was separated from plasma by centrifuging the blood. The
centrifuge was set at 3000 rpm for 10 minutes (Beckman Coulter Inc., Brea, CA). The
serum was kept at a temperature of -80 °C. After all samples of serum were collected,
Estradiol serum concentration was assessed using the TOHSO Estradiol ST AIA assay
(Fisher Healthcare Inc. Houston, TX).

Leg Skin Temperature
Leg skin temperature was measured using the forward-looking infrared 660 IR
Camera (FLIR systems, Danderyd, Sweden). This device was validated to accurately
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detect the temperature of the skin 28. To acquire best images, the readings were at a
perpendicular angle and at a distance of one meter away from the skin. Dark colored
rooms were preferred to minimize infrared interference so that test was performed in the
room with uniform Light Emitting Diode (LED) 29. Baseline leg skin temperature was
taken before ACL laxity and quadriceps elasticity measurements after stabilizing leg
temperature in a neutral environment for 20 minutes and leg skin temperature was
measured immediately when the heat pads at 38 °C were removed.

Anterior Ligament Elasticity
Knee elasticity of ACL was measured by a KT-2000 knee arthrometer (MED
metric Corp, San Diego, California). This device had been validated for over twenty
years in both clinical and research areas 30, 31. First, the knee was placed in a
predetermined position while the participant lays supine. With the knee at 90 degrees, a
strain gauge was used to measure the force necessary to generate an anterior glide of the
proximal end of the tibia on the femoral condyles. This generated a force curve of
elasticity in the anterior cruciate ligaments. The process was accomplished by supporting
both limbs with a firm, comfortable platform placed proximal to the popliteal space. This
helped keep the patient’s knee flexion angle constant for the duration of the test. Along
with this device, a foot support accessory supplied with the arthrometer, positioned the
feet symmetrically allowing the leg position to be optimal for the test while reducing
external rotation of the tibia. For the most comfortable position during the flexion angle
test, knee flexion angle was held at 25 degrees (Figure 1). A thigh strap, provided,
controlled hip external rotation while offering support allows patients to be most relaxed.
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Force used for the experiment was applied at 30 lbs. (133N) of force. The output of ACL
elasticity was displaced on an X-Y plotter. A vernier caliper was used to interpret anterior
tibal displacement (ATD) graph. A single trained investigator measured ACL laxity
measures throughout the study to minimize potential inter investigation variation.

Figure1. Experimental setup for measuring ACL elasticity, the subject was positioned
supine with their knee flexed to 25 degrees.

Muscle and Tendon Flexibility
Muscle and tendon flexibility was measured by a continuous passive motion
device (CPM). Participants were asked to sit on the edge of the table while the leg hung
freely. The knee was moved through 35 degrees of motion from 90 to 125 of knee flexion
by CPM. The FFK and KFEH measured the flexibility of muscle and tendon. An
electronic goniometer was placed on lateral side of the thigh leg to measure the degrees
13

of knee flexion while passively moving the knee. The goniometer used a ruby bearing
360 degree 5000 ohm potentiometer (Figure2). The output was digitized on Bio Pac MP
150 data collection system (Bio Pac System, Goleta, CA). The force needed to move the
leg at 115 degrees of knee flexion was used to assess difference in FFK and KFEH.

Figure2. Experimental setup for measuring FFK and FEK of the knee, the subject was
positioned sit with their hip and knee flexed to 90 degrees.

The elastic hysteresis curve, which is the difference between the FFK and force to
extend the knee (FEK), was also measured by CPM (Figure 3). Elastic energy stored
during the loading the knee (flexion) is greater than that of unloading (extension); thus,
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flexing the knee requires greater force than extending the knee

. A lower elastic

32

hysteresis value indicates more elasticity of the muscle and tendon.

Figure3. The elastic hysteresis curve, which is the difference between the FFK and FEK,
as measured by CPM.

Control of Quadriceps and Knee Temperature
Quadriceps and knee temperature were controlled with Berg’s polar care therapy
heat exchange unit (Berg Inc. East Carlsbad, CA). Water temperature of the bath was
maintained 40°C by a water bath. A heating water bath circulator (Fisher scientific Inc.
Pittsburgh, PA) was attached to the water bath to control the water bath temperature.
Since water temperature dropped about 2 °C from the water bath to the therapy pad.
Water temperature was kept at 40°C. This way each participant was given 38°C heat on
their knee and quadriceps.
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Procedures
Participants signed an informed consent form prior to their involvement. All tests
were performed seven times depending on each participant’s menstrual phases
throughout one full menstrual cycle. Since the estradiol serum concentration in blood and
body temperature fluctuates during the day, the tests were performed at the same time
each experiment day.
On the first day, physical characteristics were measured including height, weight,
BMI, and self-reporting menstrual cycle. Upon arriving to the examination area,
participants rested comfortably in a regulated ambient temperature of 22 °C for 20
minutes to stabilize their body temperature in a neutral environment. First, 4cc of blood
samples were taken to analyze estradiol serum concentration before measuring leg skin
temperature. Next, ACL elasticity, FFK, and KFEH were measured. After this, two 38°C
heat pads were placed on each participant’s quadriceps and knee for 20 minutes to control
their leg temperature, skin temperatures, ACL elasticity, FFK, and KFEH measurements
were repeated.

Data Analysis
Kolmogrov_Smirnov test was conducted to examine the distribution of estradiol
serum concentration, leg skin temperature, ACL elasticity, FFK, and KFEH. One-way
repeated measures analysis of variance (ANOVA) was used to examine mean estradiol
serum concentration, leg skin temperature, ACL elasticity, and the FFK at seven different
phases in the menstrual cycle at ambient temperature. LSD pairwise comparisons test for
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multiple comparisons was used to compare means of variables between any two different
testing phases. A mixed factorial ANOVA was conducted to compare cycle phases with
respect to the effect of estradiol on ACL elasticity, FFK, and KFEH at ambient
temperature and 38°C warming. The level of significance was set at p < 0.05.

Results
The distribution of estradiol serum concentration, leg skin temperature, ACL
elasticity, FFK, and KFEH was approximately normal (p>0.05). Mean and Standard
Deviation (SD) of number of days, estradiol serum concentration, and leg skin
temperature in seven different phases of the menstrual cycle is listed in Table 2. The
Participant’s phases were determined by their self-report and estradiol serum
concentration. Mean (SD) of the Anterior tibial displacement (ATD), FFK and KFEH at
ambient temperature and 38°C warming in seven different testing phases during the
menstrual cycle are shown in Table 3.
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Table2. Summary of Outcome Variables in 7 Different Test Phases during the Menstrual Cycle (N=10)

Outcome Measure

M

EF

LF

O

EL

ML

LL

p- value

Mean
(SD)
2.2
(0.8)

Mean
(SD)
6.3
(1.38)

Mean
(SD)
10.2
(1.28)

Mean
(SD)
14.2
(2.2)

Mean
(SD)
17.8
(2.7)

Mean
(SD)
23.4
(2.4)

Mean
(SD)
28.1
(3.2)

<0.001

Estradiol, pg/ml

51.4
(9.0)

68.3
(14.3)

82.5
(17.6)

175.8
(45.9)

103.9
(26.3)

130.3
(38.8)

68.7
(17.0)

<0 001

Knee skin temperature, °C

31.8
(0.7)

31.4
(0.4)

31.7
(1.0)

31.5
(0.8)

31.9#*
(0.8)

31.8#
(0.5)

31.8#
(0.6)

0.39

Quadriceps skin temperature, °C

31.8
(0.9)

31.5
(0.5)

31.8
(1.1)

31.6
(0.7)

32.1#*
(1.0)

31.9#
(0.7)

31.9
(0.98)

0.29

Number of days
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Abbreviations: SD, Standard deviation; M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; EL,
Early Luteal; ML, Middle Luteal; LL, Late Luteal
^
Significant changes from menstruation
#
Significant changes from early follicular phase
*
Significant changes from ovulation phase

Table3. Summary of Biomechanical Variables in 7 Different Test Phases during the Menstrual Cycle at Ambient
temperature and 38°C warming (N=10)
ATD, mm
Pre Heat

Post Heat

Mean(SD)

Mean(SD)

M

5.1(1.5)*

5.5(1.6)*^

EF

5.4(1.5)*^

LF

FFK, N
Pre Heat

Post Heat

Mean(SD)

Mean(SD)

<0.01

126.0(35.4)*^

113.2(23.8)

5.5(1.8)*

0.43

123.9(34.2)

5.4(1.7)*

5.6(1.7)

0.24

O

5.9(1.7)

^

6.0(1.8)

EL

5.4(1.6)*

ML
LL

Phase
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p-value

b

FKEH, N
Pre Heat

Post Heat

Mean(SD)

Mean(SD)

0.04

34.4(9.1)*^

28.4(8.0)

<0.01

112.0(31.3)

0.05

30.0(8.7)*

26.9 (10.4)

0.07

116.6(38.0)

110.9(34.6)

0.01

28.9 (7.4)^

25.0 (9.2)

0.03

0.41

111.2(24.6)

109.0(25.9)

0.36

27.0(6.0)

24.2(8.7)

0.44

5.8(1.7)

0.02

122.4(31.9)

111.5(31.2)

<0.01

30.6 (7.2)*

25.5(7.8)

0.05

5.7(1.7)^

5.8(1.6)

0.66

115.2(18.4)

108.9(30.2)

0.2

30.0(7.0)*

25.6(5.3)

0.02

5.2(1.2)*

5.4(1.0)

0.26

122.1(27.7)

112.0(27.4)

0.02

30.9 (9.1)

24.9(6.8)

<0.01

0.03

0.35

0.2

0.82

0.06

0.71

p-value a

p-value a

p-value a

Abbreviations: SD, Standard deviation; M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; EL Early
Luteal; ML, Middle Luteal; LL, Late Luteal
^

Significant changes from menstruation
Significant changes from early follicular phase
*
Significant changes from ovulation phase
a
p- values for the null hypothesis that there is a no difference between pre and post heat
b
p- values for the null hypothesis that there is a no difference across 7 phases of the menstrual cycle
#

Estradiol Serum Concentration
As shown in Figure 4, estradiol concentrations significantly changed throughout
the menstrual cycle (p<0.001). The lowest estradiol concentration was found during
menstruation (51.4±9.0 pg/ml) and the peak of estradiol concentration was found during
ovulation (175.8±45.9 pg/ml, Table 2).

Estradiol serum concentration (pg/ml)

Estradiol Serum Concentration
240
200
160
120
80
40
0
M

EF

LF

O

EL

ML

LL

Cycle Phase +

Figure4. Mean ± SD of estradiol serum concentration measured in 7 different phases
during the menstrual cycle.
+

Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation;
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal

Leg Skin Temperature
Results indicated that there were no significant differences in knee and quadriceps
skin temperatures during the menstrual cycle at ambient temperature (p>0.05, Table 2).
However, there was a significant difference in knee skin temperature between the early
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follicular and the early luteal phase (31.4 ± 0.4 °C vs. 31.9±0.8 °C, p=0.01). The
quadriceps skin temperature was also significantly higher in the early luteal phase than
early follicular phases (32.3±1.0 °C vs.31.5 ±0.5 °C, p=0.04). Leg skin temperature
significantly increased and held at 38 °C warming when two heat pads were applied on
the knee and quadriceps.

Anterior Knee Ligament Elasticity
Anterior knee ligament elasticity was a measure of ATD. The greatest ATD
during ovulation occurred both at ambient temperature and after 38 °C warming (Figure
5). ATD during ovulation was significantly higher than any other phase at ambient
temperature (p=0.03). There was also a significant difference in ATD between
menstruation and ovulation as well as between early follicular and menstruation at 38 °C
warming (p<0.05, Table 3). The greatest ATD was observed when estradiol peaks while
the opposite occurred with lower estradiol concentration across the seven phases during
the menstrual cycle. There were significant differences in ADT between ambient
temperature and 38 °C warming during menstruation and early luteal phases (Table 3).
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Anterior Tibial Displacement (ATD)

Displacement (mm)

8
7
6
ambient temp.

5

38 °C warming
4
3
M

EF

LF

O

EL

ML

LL

Cycle Phase +

Figure5. Mean ± SD of the ATD measured in 7 different phases during the menstrual
cycle at ambient temperature and 38°C warming.
+

Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation;
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal

Measurement of Muscle and Tendon Flexibility
Force to Flex the Knee (FFK)
The FFK decreased 15% from menstruation to ovulation at ambient temperature
(p=0.4, Table 3). However, no significant changes in FFK across the menstrual phases at
38 °C warming were detected (p>0.05, Table 3). Also, a significant difference was found
in the FFK in between the ambient temperature and 38°C warming all the phases except
the ovulation and the middle luteal phase in which estradiol concentrations were
relatively higher than other phases (Table 3, Figure 6).
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Force to Flex the Knee (FFK)
180
160

Force (N)

140
120

ambient temp.
38 °C warming
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Figure6. Mean ± SD of the FFK measured in 7 different phases during the menstrual
cycle at ambient temperature and 38°C warming.
+

Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation;
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal

Knee Flexion-Extension Hysteresis (KFEH)
Figure 4 shows the KFEH curve across the seven phases. As shown in Figure 7,
there were significant differences of KFEH over the phases at ambient temperature. The
KFEH increased 25% from ovulation to menstruation (26.0±6.0 N vs. 34.5±9.1 N, p<0.
01), 15% from ovulation to the early luteal (26.0±6.0 N vs.30.63±7.23 N, p=0. 04), and
13% from ovulation to the middle luteal phases (26.0±6.0 N vs.29.97±6.98 N, p=0. 03).
However, there were no significant changes in the KFEH over the phases at 38 °C
warming (p>0.05). The KFEH was significantly higher at 38 °C warming as compared to
that at ambient temperature in all phases except the ovulation (P<0. 05, Figure 6).
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Knee Felxtion-Extension Hysteresis (KFEH)
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Figure7. Mean ± SD of the KFEH measured across the 7 different phases during the
menstrual cycle at ambient temperature and 38°C warming
+

Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation;
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal

Discussion
ACL injury is more common in women compared to men who participate in the
same activities. Numerous studies have been conducted on changes of knee ligament
elasticity during the menstrual cycle to examine the correlation between sex hormones,
which fluctuate over the menstrual cycle, and ACL laxity 33, 34. In spite of that,
researchers are still debating on the results of these studies because the study methods
and procedures were vastly different. Increased tissue temperature could be one factor
that causes ligament and tendon laxness 16. In this investigation, ACL elasticity, FFK,
and KFEH were measured during seven different phases of the menstrual cycle at
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ambient temperature and after warming the leg to 38 °C in young healthy women with a
regular menstrual cycle.
The most important finding of the present study was a significantly greater ACL
elasticity, less FFK, and KFEH during ovulation where estradiol concentration peaks
compared to the mensturation where estradiol level is lowest during the menstrual cycle.
The relationship between sex hormones, especailly, estrogen and knee ligament elasticity
as well as between estrogen and musculotendinous stifnesss in young women with a
regular mentrual cycle, has been demonstrated 13, 35-37. However, this study is the first to
examine the relationship between estradiol serum concentration and knee elasticity and
its relationship to tissue temperature in young healthy women with a regular menstrual
cycle. Greater ACL elasticity was found to occur during ovulation. There are two factors
that may cause this: 1) estrogen and 2) tissue temperature. Heat is generally used to
increase the elasicity and flexibility of soft tissues 38. Ligaments must have more
elasticity with relatively higher temperature since these are elastic stuctures 43. In this
investigation, skin temperature was comparably lower during ovulation than menstruation
and the early follicular phase. But the only improtant temperature is the temperature of
deep tissue. There are very few papers on deep shell tissue temperature in deep tissues
during the menstrual cycle 22. These investigations found that muscle temperature was
significantly elevated during ovulation and the well documented increase in core
temperature. This is because heat has to be conserved by skin to get increased body
temperature. Heat goes through the muscle and leaves the skin by radiation, convection,
conduction, and evaporation. Skin needs to be cooler than the core temperature to aid in
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heat loss or conserve heat 25. Therefore, to keep the body cool at ovulation, the shell
needs to remove more heat; hence muscle temperature increases at ovulation.
When the knee was heated to 38 °C, there was still difference in ACL elasticity at
ovulation when compared to other phases of the menstrual cycle. Therefore, while the
temperature change in deep tissues causes increased laxness, so must estradiol. Both are
synergistic at ovulation in increasing ACL elasticity. However, previous studies
examining ACL elasticity did not control tissue temperature. Therefore, if it was a cool
day, the cool temperature of the shell would increase ACL stiffness and its effect would
be cancelled. Clothing and ambient temperature become important to consider in studies
and may be the reason the results were so varied in different studies. No previous study
has even had subjects acclimatized to room temperature before measuring measurements.
This study also measured the FFK and KFEH in knee felxion and extension.
These measures examined muscle and tendon flexibility. Human muscles and tendons are
soft tissues composed of collagen fibers, which may be also affected by estradiol
concentration and temperature as explained above. Results of this sutdy showed a
significantly lower FFK and KFEH at ovulation compared to menstruation. This finding
indicates that less muscle and tendon stiffness are shown in the ovulation than
menstruation statge. In addition, this result may infer that less muscle flexibility occurs
with increased estradiol concentration and lower skin temperature which may lead to
higher muscle tissue temperautre in young healthy women. However, for the knee, the
probable effect of estradiol is different. There was more energy storage at ovulation
showing increased laxity. When the leg was warmed to the core temperature, this effect
disappeared. This result implies that the flexibility is more affected by temperature than
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estrogen; although estrogen is responsible for the temperature fluctuation. Thus, using
heat would be beneficial on increasing knee flexibility; the optimal time would be in the
menstruation and early follicular phase, where the less flexibility occurs.
Knee joint stiffness is a major risk factor for non-contact ACL injuries 39. It is so
common for athletes to do warm-up stretching or use heat packs to decrease stiffness
before exercise for injury prevention 40. Women have greater knee stiffness due to
estradiol and temperature effects during menstruation. However, this investigation did
not examine how knee stiffness is related to injuries. Laxity may cause injuries or may
not. Myklebust and colleague and Slatuterbeck and colleague reported that there are more
ACL injuries during menstruation where less ACL elasticity was found 41, 42. On the other
hand, Wojtys and colleague claimed that more ACL injuries occur during ovulation
where greater ACL elasticity was found 43. However, these studies did not control
environment or tissue temperature. Temperature may be another factor that affects ACL
injuries but previous studies did not examine ACL elasticity under the same condition
such as controlling the effects of clothing or environment temperature. If women play
sports during ovulation in a hot environment, both temperature and estrogen causes
excessive knee laxity which can leads to more knee injuries. However, if women play
sports during menstruation in cold environments, both temperature and estrogen cause
excessive knee stiffness that can lead to more knee injuries. Thus, in further investigation,
both estrogen and temperature should be considered as key risk factors that can cause
ACL injuries during menstrual cycle.
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Conclusions
ACL elasticity, FFK, and KFEH were affected not only by estradiol serum
concentration but tissue temperature during the menstrual cycle. However, estradiol
serum concentration had more impact on ACL laxity while tissue temperature had
more impact on FFK and KFEH at 38 °C warming.
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Abstract
Introduction: Eighty two percent of sexually active women aged 15-44 have used
oral contraceptive pills (OCP) in the United States. Hormone changes during the
menstrual cycle (MC) are believed to have an impact on anterior cruciate ligament (ACL)
laxity due to estrogen. OCP may have a potention impact on tendon and ligament
synthesis, structure, and biomechanical properties. Temperature has also been known to
have an effect of on tissue elasticitiy. Therfore, the purpose of this study was to
investigate the differences in ACL elasticity, force to flex the knee (FFK), and knee
flexion-extension hysteresis (KFEH) between OCP users and non-OCP users and its
relationship to tissue temperature. Methods: Nineteen non-athletic young healthy
females were divided into two groups; OCP users and non-OCP users. Blood for estradiol
serum concentration (E2) was taken before beginning the tests. ACL elasticity, FFK, and
KFEH were assessed both at ambient temperature (22 °C) and after 38 °C warming of the
leg to stabilize the tissue temperature. Assessments were performed four times during the
MC. Results: Throughout the MC, ACL elasticity, FFK, and KFEH fluctuated in nonOCP users but not in OCP users. At ambient temperature, ACL elasticity was significantly
lower and FFK and KFEH were significantly higher in OCP users than non-OCP users
(p<0.05). But, no significant differences in FFK and FFEH between the two groups were
found after warming to 38 °C.
Conclusions: The effect of MC on ACL is both hormonal and temperature related while
the knee is temperature related.
Key words: Oral contraceptive pill, Knee elasticity, Muscle and tendon flexibility, and
Tissue temperature
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Introduction
Women have a greater incidence of Anterior Cruciate Ligament (ACL) injury
than men 1-4. This gender differnce is commoly assumed to be due to anatomical,
neuromuscular, movement patterns, in women as well as hormonal influences 4, 5.
Regarding hormonal factors, numerous studies have found a correlation between
reproductive hormones and ACL injury risk 1-4. The role of estrogen in possibly causing
ACL injuries has recently been studied at the celluar level and the presence of 17- beta
estradiiol receptors in human ACL and muscle has been investigated 6-9. Previous studies
have examined the changes in the levels of estrogen in blood as related to ACL laxity
during the menstrual cycle and a correlation between ACL laxity and estrogen was
detected 6-9.
The number of women using OCP has constantly increased. Eighty two percent
of sexually experienced women aged 15-44 have used the oral contraceptive pill (OCP)
in the United States and 14% of women have used OCP for non-contraceptive purposes
such as cycle regulation, treatment of dysmenorrhea and amenorrhea 10. OCP consists of
combined estrogen and progesterone as synthetic steroids and it plays a role in
suppressing pituitary FSH and LH production and preventing ovulation from occurring 10,
11

. This exogenous source of synthetic forms of the hormone prevents ovulation by

maintaining more consistent hormone levels 12. The 17- beta estradiol receptors on human
connective tissue is well known and therefore, the OCP may have an impact on tendon
and ligament synthesis, structure, and biomechanical properties. Also, Martineau and
colleagues have shown that OCP usesrs have less ACL laxity than non-OCP users 13.
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It is not surprising that many people do a warm-up exercise before sports
activities to increase muscle and tendon extensibility to prevent injuries 14. Temperature
is another factor that influences tendon and ligament of collagen synthesis. In healthy
young adults, core temperature changes approximately 0.5°C throughout the day. In
women with a regular menstrual cycle, their core temperature fluctuates not only
throughout the day but also during the menstrual cycle 15. It peaks during the luteal
phase while in the follicular and at ovulation it is relatively low 15-17. The elevated
thermoregulatory set point during the luteal phase is the most accepted explanation for
the observed change in core temperature 18, 19. Since, soft tissue extensibility changes with
different levels of tissue temperature; the menstrual cycle has dramatic effects on tissue
extensibility. However, because hormones do not change in OCP users, their core
temperature may change little during the menstrual cycle. In addition, Rogers and Baker
have shown that OCP users have higher core temperature compared to non-OCP users
due to exogenous forms of progesterone in OCP’s 20.
Thus, the effect of estrogen on ACL elasticity and muscle and tendon flexibility is
probably a complex interaction between the hormone and tissue temperature. Therefore,
the purpose of this study was to investigate the differences in ACL elasticity, force to flex
the knee (FFK) and knee flexion-extension hysteresis (KFEH) between OCP users and
non-OCP users and its relationship to tissue temperature during the menstrual cycle.

Materials and Methods
Subjects
Twenty non-athletic young healthy females volunteered to participate in this
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study. Subjects were divided into two groups: subjects with a regular menstrual cycle and
those who are taking OCP according to their self-reporting. Subjects were 18 to 30 years
of age with a Body Mass Index (BMI) between 15 and 30 who had a regular menstrual
cycle or currently using low-dose OCP (<50µg-ethinyl estradiol) for at least six months.
Subjects had no history of pregnancy, neuropathy, myopathy or knee injury, and were not
taking any medication would affect sex hormones other than OCPs. All procedures and
protocols were approved by Institutional Review Board of Loma Linda University and all
subjects signed an informed consent.

Procedures
Subjects performed a total of four different tests throughout one full menstrual
cycle. Subjects were asked to report the days of their cycle at the beginning of the study.
OCP users were screened by questionnaire, which included questions regarding brand
name, type, and the length of taking OCP. At the beginning of the study, subjects signed
an informed consent before they participated in the study. Since the estradiol serum
concentration in blood and body temperature fluctuates during the day, the various tests
were performed at the same time each day.
On the first day, before beginning the experiment, height, weight, BMI, and selfreported menstrual cycle were measured. Upon arriving at the laboratory, subjects rested
comfortably in a regulated temperature room at 22 °C for 20 minutes to stabilize their
body temperature in a neutral environment. Blood samples (4cc) were taken to analyze
estradiol serum concentration before measuring leg skin temperature. Next, ACL
elasticity, FFK, and KFEH were measured. After this, two 38°C heat pads were placed on
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the subject’s quadriceps and knee for 20 minutes to stabilize their leg temperature. Skin
temperature, ACL elasticity, FFK, and KFEH measurements were repeated.

Measurements
A trained researcher performed all measurements. The outcome variables assessed
were ACL elasticity, force to flex the knee (FFK), knee flexion-extension hysteresis
(KFEH), leg skin temperature, and estradiol serum concentration.

Estradiol (E2) Serum Concentration
Estradiol serum concentration was analyzed using the TOHSO E2 ST AIA assay
(Fisher Healthcare, Inc., Houston, TX, USA). Four cc of blood was obtained from an
antercubutal vein with a 23-guage needle and centrifuged for separating serum from
plasma. The centrifuge rotated at 3000 rpm for 10 minutes (Beckman Coulter Inc., Brea,
CA). Once serum was separated, it was stored at -80°C until all samples of serum were
collected for the hormone analysis.

Leg Skin Temperature
Leg skin temperature was measured using the forward-looking infrared 660 IR
Camera (FLIR systems, Danderyd, Sweden). This device has been validated to deliver
accurate temperature measurements 21. To acquire best images, the readings were at a
perpendicular angle and at a distance of 1 meter away from the skin. Measurements were
performed in the room illuminated with light emitting diode (LED) lights to minimize
any infrared interference 21. Baseline leg skin temperature was taken after stabilizing leg
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temperature at a neutral environment for 20 minutes and after applying 38 °C heat
immediately when the heat pads were removed.

Anterior Knee Ligament Elasticity
KT-2000 knee arthrometer (MED metric Corp, San Diego, California) was used
to measure knee laxity of the anterior cruciate ligament. The measurement of the anterior
knee ligament laxness was performed by one experienced examiner for consistency.
Subjects were asked to lay supine in a predetermined position. A strain gauge was used to
measure the force necessary to generate an anterior glide of the proximal end of the tibia
on the femoral condyles. This generated a force curve of elasticity in the anterior cruciate
ligaments. The process was accomplished by supporting both limbs with a firm,
comfortable platform placed proximal to the popliteal space. This helped keep the
subject’s knee flexion angle constant for the duration of the test. Along with this device,
a foot support accessory supplied with the arthrometer, positioned the feet symmetrically
allowing the leg position to be optimal for the test while reducing external rotation. For
the most comfortable position during the flexion angle test, knee flexion angle was held
at 25 degrees (Figure 8). A thigh strap controlled hip external rotation while offering
support in order to help relax the subject. Force used for the experiment was applied at
30 lbs. (133N) of force. The force displacement data was shown on an X-Y plotter. A
venire caliper was used to measure anterior tibial displacement (ATD) graph.
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Figure8. Experimental setup for measuring ACL elasticity, the subject was positioned
supine with their knee flexed to 25 degrees.

Muscle and Tendon Flexibility
The angle of the force measured to extend the knee was from 90 to 125 degrees.
Elevated off the floor and in a seated position, the subject's leg hung at an initial angle of
90 degrees.

To passively move the knee through 35 degrees of flexion and extension,

an ankle strap was connected to a linear actuator (Figure 9). The measurement was
recorded at a rate of movement of 45 degrees in 7.5 seconds.

The force in flexion and

extension was measured with a strain gage bridge amplified with a gain of 500(DAC 100,
Bio Pac Systems, Goleta California). The output was then digitized at 2000 hertz with a
resolution of 24 bits on an MP150 Bio Pac data acquisition system (Bio Pac Systems,
Goleta California). The knee goniometer, using a ruby bearing 360 degree 5000 ohm
potentiometer, measured the angle of the knee to calculate the force needed per degree
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Figure9. Experimental setup for measuring FFK and FEK of the knee, the subject was
positioned sitting with their hip and knee flexed to 90 degrees.

The difference between the FFK and force to extend the knee (FEK), called
KFEH, was then calculated. Potential elastic energy stored during the loading (flexion)
is greater than that of unloading (extension); thus, flexing the knee required greater force
than extending the knee 22. A lower elastic hysteresis value means more elasticity of the
muscle and tendon (Figure 10).
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Figure10. The elastic hysteresis curve, which is the difference between the FFK and FEK,
as measured by CPM.

Control of Quadriceps and Knee temperature
Quadriceps and knee temperature were controlled with a Berg’s polar care
therapy heat exchange unit (Berg Inc. East Carlsbad, CA) maintained at 40°C by a water
bath. On the water bath, a heating water bath circulator (Fisher scientific Inc. Pittsburgh,
PA) was attached to control temperature. Since water temperature dropped about 2 °C
throughout the unit, water temperature was kept at 40°C to give 38°C heat on subject’s
knee and quadriceps.
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Data Analysis
Data was summarized using means and standard deviation (SD). An independent
t-test was conducted to compare general characteristics between OCP users and non-OCP
users. One-way repeated measures analysis of variance (ANOVA) was used to examine
changes in mean estradiol serum concentration, leg skin temperature, ACL elasticity,
FFK, and KFEH at four different phases of the menstrual cycle. For significant findings,
LSD pairwise comparisons test for multiple comparisons was used to compare means of
variables between any two different phases. For all data collected over the phases within
each test, a mixed factorial ANOVA was conducted to compare cycle phases with respect
to the effect of estradiol concentration on ligament elasticity, FFK, and KFEH at room
temperature and 38°C in each group. The level of significance was set at p < 0.05.

Results
Ten subjects were enrolled in each group. However, one subject from the OCP
group was excluded because the estradiol level was similar to that of a normal menstrual
cycle subject. There were no significant differences in mean age, weight (kg), height
(cm), BMI (kg/m2), and length of cycle (p>0.05, Table 4). The subject’s menstrual phase
was determined by their self-reporting and estradiol serum concentrations. Mean (SD) of
the ADT, FFK, and KFEH at ambient temperature and 38°C warming in four different
phases during the menstrual cycle is shown in Table 6,5,7.
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Table 4. Mean (SD) of general characteristics (N= 19)
Non-OCP users

OCP users

p –value*

Age (years)

24.7 (2.0)

25.1(3.3)

0.74

Height (cm)

164.6 (3.4)

165.7(5. 1)

0.59

Weight (kg)

57.1 (5.0)

59.4(7.0)

0.35

BMI (kg/m2)

21.0 (1.3)

21.6(4.1)

0.48

Cycle length (d)

29.5 (3.2)

28.6(1.1)

0.38

Abbreviation: SD, Standard deviation; OCP, Oral contraceptive pills
* Independent t-test

Table 5. Summary of Outcome Variables in 4 Different Test Phases during the Menstrual
Cycle (N=19)
Outcome Measure

M

F

O

L

Mean
(SD)

Mean
(SD)

Mean
(SD)

Mean
(SD)

P-value

Non-OCP users

2.2(0.8)

10.2(1.3)

14.2(2.2)

23.4(2.4)

<0.001

OCP users

2.1(0.5)

9.1(0.9)

13.8(1.2)

22.9(1.6)

<0.001

Non-OCP users

51.4 (8.9)

82.5 (17.6) 175.8 (45.9) 130.3 (38.8) <0.001

OCP users

29.6 (5.3)

34.8 (11.1) 31.3 (9.7)

32.7 (9.9)

0.42

Non-OCP users

31.8(0.7)

31.7(1.0)

31.5(0.8)

31.8(0.5)#

0.43

OCP users

31.8(0.3)

31.8(0.3)

31.7(0.3)

31.9(0.5)

0.74

Non-OCP users

31.8(0.9)

31.8(1.1)

31.6(0.7)

31.9(0.7)#

0.52

OCP users

31.9(0.7)

31.8(0.8)

32.0(1.3)

31.9(0.9)

0.88

Number of days

Estradiol, pg/ml

Knee skin temperature, °C

Quadriceps skin temperature, °C

Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral
contraceptive pills
#
Significant changes from ovulation
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Estradiol (E2) Serum Concentration
Mean and SD of estradiol serum concentrations in four different phases during the
menstrual cycle is displayed in Table 5. There were significant changes in estradiol serum
concentration found across the menstrual cycle in the OCP user group (P<0.001), but not
in OPC group (Figure 11, Table 2). The lowest estradiol concentration was found during
menstruation (51.4±9.0 pg/ml) and the highest estradiol concentration was found during
ovulation (175.8±45.9 pg/ml) in non-OCP user group (Table 5).

Estradio serum concentration (pg/ml)

Estradiol Serum Concentration
240
200
160
120

non-OCP users
OCP users

80
40
0
M

F

O

L

Figure11. Mean ± SD of estradiol concentration measured in 4 different phases of the
menstrual cycle in non-OCP users and OCP users.
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills

Leg Skin Temperature
Both knee and quadriceps skin temperatures were significantly lower during
ovulation compared to luteal phase in non- OCP users (31.5 ±0.8 vs. 31.8 ±0.5, p=0.04,
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31.6±0.7 vs. 31.9±0.7, p=0.04, Table 5). However, there were no significant changes
during the menstrual cycle in non-OCP users (p>0.05, Table 5). Also, no significant
differences in temperature were detected between OCP users and non-OCP users in all
phases (p>0.05). When two heat pads were applied on the knee and quadriceps skin
temperature significantly increased and held at 38 °C warming

Anterior Knee Ligament Elasticity
Anterior knee ligament elasticity was measured by ATD. The results of the ATD
changes in four different phases during the menstrual cycle at ambient temperature and
after 38°C warming in non-OCP and OCP users are shown in Figure 12. When
comparing ATD in four different phases of the menstrual cycle, ATD was significantly
lower in OCP users compared to non-OCP at both temperatures (Figure 12). The greatest
ATD was found at ovulation and the least ATD was found at menstruation in non-OCP
users (Table 6). At ambient temperature, the ATD decreased 10% from ovulation to
menstruation and the ATD differences between ovulation and menstruation were not
significant in OCP users (p>0.05, Table 6). There were significant differences in ATD
between OCP users and non-OCP users (p>0.05) after applying 38 °C warming, There
was a significant difference in ATD between ovulation and menstruation in OCP users
(6.0 ± 1.8 mm vs. 5.6± 1.6 mm, p=0.01, Table 6, Figure 12).
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Table 6. Mean (SD) of the ATD measured in 4 different phases of the menstrual cycle at
ambient temperature and after 38°C warming in non-OCP users and OCP users (N=19).
Anterior Tibial Displacement, mm
Group

Non-OCP users
Pre Heat

Post Heat

Mean (SD)

Mean (SD)

M

5.1(1.5)

5.5(1.6)

F

5.4(1.7)

O
L

Phase

p-value

b

OCP users
Pre Heat

Post Heat

p-

Mean (SD)

Mean (SD)

value a

<0.01

4.4(0.8)

4.5(1.0)

0.51

5.6(1.7)

0.24

4.3(0.9)

4.5(0.9)

0.16

5.9(1.7)*^

6.0(1.8)*

0.41

4.4(0.9)

4.6(0.9)

0.08

5.7(1.7)*

5.8(1.6)

0.67

4.4(0.6)

4.6(0.8)

0.32

<0.01

0.44

0.89

0.97

p-value a

Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral
contraceptive pills
*
Significant changes from menstruation
^
Significant changes from follicular phase
a
p- values for the null hypothesis that there is a no difference between pre and post heat
b
p- values for the null hypothesis that there is a no difference across 4 phases of the menstrual cycle
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(A)

Anteiror Tibial Displacement (ADT)
(ambient temperature)

Displacement (mm)

8
7
6
non-OCP users

5

OCP users

4
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Cycle Phase

(B)

Anteiror Tibial Displacement (ADT)
(38 °C warming )

Displacement (mm)

8
7
6

non-OCP users

5

OCP users

4
3
2
M
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L

Cycle Phase

Figure12. Mean ± SD of the ATD measured in 4 different phases of the menstrual cycle at
ambient temperature and after 38 °C warming in non-OCP users and OCP users.
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills
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Measurement of Muscle and Tendon Flexibility
Force to Flex the Knee (FFK)
The FFK decreased 15% from menstruation to ovulation at ambient temperature
in non-OCP users (p=0.04, Table 7). However, there were no significant changes in the
FFK across the phases at 38 °C warming (P>0.05). Also, a significant difference was
found in the FFK between the ambient temperature and 38°C warming in all phases
except ovulation in which estradiol concentrations were relatively higher than in other
phases (Table 7). Both at ambient temperature and 38 °C warming, the FFK of OCP
users were greater than non-OCP users in all phases (Table 7, Figure 13). There was no
significant difference in the FFK between pre and post heat in OCP users. On average,
9.5% decrease was shown in OCP users versus 5.4% decrease in non-OCP users (Table
7).

Table 7. Mean (SD) of the FFK measured in 4 different phases of the menstrual cycle at
ambient temperature and after 38°C warming in non-OCP users and OCP users (N=19).
Force to Flex the Knee, N
Group

Non-OCP users
Pre Heat

Post Heat

Mean (SD)

Mean (SD)

M

126.0(35.4)

113.2(23.8)

F

116.6(38.0)

O
L

Phase

p-value b

OCP users
Pre Heat

Post Heat

Mean (SD)

Mean (SD)

0.04

132.5(26.1)

118.0(25.6)

<0.01

110.9(34.6)

0.01

128.2(28.1)

117.1(23.5)

0.04

111.2(24.6)*

109.0(25.9)

0.36

130.9(30.0)

117.6(24.5)

<0.01

115.2(18.4)

108.9(30.2)

0.21

129.8(32.3)

119.2(24.9)

0.02

0.24

0.89

0.92

0.99

p-value a

p-value a

Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral
contraceptive pills
*
Significant changes from menstruation
a
p- values for the null hypothesis that there is a no difference between pre and post heat
b
p- values for the null hypothesis that there is a no difference across 4 phases of the menstrual cycle
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Figure13. Mean ± SD of the FFK measured in 4 different phases of the menstrual cycle at
ambient temperature and after 38 °C warming in non-OCP users and OCP users.
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills
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Knee Flexion-Extension Hysteresis (KFEH)
At ambient temperature, the KFEH was significantly lower in OCP users than nonOCP users. During ovulation, the KFEH was significantly lower in non-OCP users than
OCP users (27.0 ± 6.0 N vs. 34.9±11.2 N, p<0.01, Table 8). Across phases, there were no
significant changes in the KFEH in non-OCP users (p=0.01) but not in OCP users
(p=0.72). The KFEH increased 24% from ovulation to menstruation at ambient
temperature in non-OCP users. In addition, there were no significant changes in the
KFEH across the menstrual cycle at 38 °C warming in OCP users (p>0 .05). In both
groups, the KFEH was significantly lower at 38 °C warming when compared to ambient
temperature in all phases except ovulation. After 38 °C warming The KFEH decreased
21.1% in OCP users and 14.0% in non-OCP users (Figure 14, Table 8).

Table 8. Mean (SD) of the KFEH measured in 4 different phases of the menstrual cycle at
ambient temperature and after 38°C warming in non-OCP users and OCP users (N=19).
Knee Flexion-Extension Hysteresis, N
Group

Non-OCP users
Pre Heat

Post Heat

Mean (SD)

Mean (SD)

M

34.4(9.1)

28.4(8.0)

F

28.9 (7.4)*

O
L

Phase

p-value b

OCP users
Pre Heat

Post Heat

Mean (SD)

Mean (SD)

value a

<0.01

38.0(14.9)

29.3(8.0)

0.02

25.0 (9.2)

0.03

35.3(14.0)

28.2(11.0)

0.04

27.0(6.0)*

24.2(8.7)

0.44

34.9(11.2)

28.1(11.2)

0.07

#

25.6(5.3)

0.02

36.0(11.1)

28.1(6.9)

0.02

0.72

0.95

30.0(7.0)
0.01

p-value a

0.45

p-

Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral
contraceptive pills
*
Significant changes from menstruation
# Significant changes from ovulation
a
p- values for the null hypothesis that there is a no difference between pre and post heat
b
p- values for the null hypothesis that there is a no difference across 4 phases of the menstrual cycle
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Figure 14. Mean ± SD of the KFEH measured in 4 different phases of the menstrual cycle
at ambient temperature and after 38 °C warming in non-OCP users and OCP users.
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills
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Discussion
ACL elasticity and muscle and tendon flexibility are major risk factors for knee
injuries during sports 23, 24. Women have fluctuating estrogen during the menstrual cycle,
and are more susceptible to have injuries 25. In previous studies, women had greater knee
laxity during ovulation at a time when estrogen level peaks 26-28. The finding supports
these results that estrogen receptors are found in connective tissue and thus, it changes its
mechanical properties of tendons and ligaments 7, 28. However, OCP makes women’s
hormone level more consistent during the menstrual cycle. If it is true that female
reproductive hormones cause connective tissue laxness, female OCP users should show
more stable tissue extensibility. Therefore, it is of no surprise that the few studies
addressing the effects of OCP on knee injury prevention show little change in ligament
elasticity during the menstrual cycle 29, 30. Researchers, however, have reached different
conclusions on the relationship between OCP and knee laxity 13, 30.
In the present investigation, ACL elasticity, FFK, and KFEH were measured
during four different phases of the menstrual cycle with subjects exposed to ambient
temperatures. In addition, to stabilize temperature fluctuation from the day, the
experiments were repeated by warming the leg to 38°C in both young healthy OCP and
non-OCP users. We have found that non-OCP users have a greater ACL elasticity, less
FFK, and KFEH in all phases compared to OCP users at ambient temperature. We futher
found that non-OCP users’ biomechanical outcome varaibales were altered throughout
the mesntraul cycle, but not in OCP users during the menstrual cycle. When comparing
estradiol serum concentration between the two groups, OCP users estradiol levels were
lower in all phases and did not alter during the menstrual cycle. These results imply that
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estradiol serum concention has an impact on human ligament, muscle, and tendon. In
other words, more knee stiffness was found in women on OCP. Here estradiol was lower
in blood.
Tissue temperature is one of the factors that alters knee elasticity and heat is
commonly used to reduce soft tissue stiffness 31. Since basal body temperature fluctuates
during the menstrual cycle, it is used to accurately detect if women are ovulating. This
change is also influenced by progesterone and estrogen during the menstrual cycle but
not in OCP users 32, 33. Previous research found that muscle temperature increased on
ovulation and it continuosly remaind elevated during the luteal phase 15, 17. To increase
central core temperature, the skin remove less heat to reduce body tempearture than skin
loose more heat. In non-OCP users, muscle and shell tissue temperatrue fluctuate during
the menstraul cycle; thus playing an important role in knee elasticity.
In addition, there were heat effects on muscle and tendon flexibility both in nonOCP and OCP uesers. The FFK and FFEH significantly decreased after 38 °C warming
of the leg in all phases in OCP users. In a similar manner, knee flexibility was
significantly reduced after using heat in all phases of the menstrual cycle except
ovulation, where estradiol serum concentration was relatively higher in non-OCP users.
These results imply that muscle and tendon flexibility is more affected by temperature
than estrogen. Interestingly, we found that FFK and FFEH decreased more after 38 °C
warming in OCP users compared to non-OCP users during the menstrual cycle. This
indicated more effect of heat on FFK and KFEH in OCP users. Thus, using heat increases
knee flexibility in OCP users and is still beneficial to non-OCP users during menstruation
where estradiol levels are relatively low. However, for the ACL, the effects of estradiol
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were different. The ADT did not significantly decrease after 38 °C warming in both
groups of subjects. Also, it was significantly higher during ovulation than menstruation
after heat.
ACL elasticity , muscle and tendon flexibility is related to knee injuries 34.
Women who are taking OCP have less knee laxity due to estradiol effects during
menstruation. Previous studies have examined the association between ACL injuires and
use of oral contraceptives 29, 35. However, results from these studies were perhaps
inconclusive because these studies did not examine the effect of both knee elasticity and
tissue temperature. It is not easy to examine the effects of OCP on ACL injuries only
with ACL elasticity. Other factors should be considered such as tissue temperature.
Thus, in further investigation, both estrogen and tissue temperature should be considered
as key risk factors that can cause ACL injuries during menstrual cycle in both OCP and
non- OCP users.
In addition, interesitngly, it is common to do a warm up prior to exercise in order
to reduceinjuries since less elasticity is relatd to tissue tears. However, in women, the
reverse seems to be true . Perhaps, the structure strength (e.g. collagen cross bridges) is
also altered by estrogen. This may explain differences in the results of some studies on
women versus men. These knee injuries may be caused by changes in collagen strength
not just elasticity. Estrogen may not only alter ACL elasticity, but may cause a change in
the breaking strength of the ACL. Just as bone can fracture due to glycogen cross linking
even when it is dense, there may be a similar relationship with collagen in ligaments
whereby they may tear even if elastic. This would involve a shift in the force stress
curve for the ACL making the elastic region shorter and the plastic region larger due to
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estrogen. There are no studies on structural strength of the ACL in relation to estrogen,
only elasticity. It will be interesting to see if there are collagen structure strength changes
during the menstrual cycle and its relationship to incidence of knee injuries in OCP users
and non-OCP users.
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CHAPTER FOUR
DISCUSSION

Women have a higher risk factor for ACL injuries compared to men who
participate in the same sports activities 3-6. ACL elasticity and muscle and tendon
flexibility are major risk factors for knee injuries during sports 42, 43. Numerous studies
have studied changes in knee ligament elasticity during the menstrual cycle to examine
the relationship between sex hormones and ACL laxity 44, 45. In several previous studies,
women had greater knee laxity during ovulation at a time when estrogen level peaks 23, 35,
46

. The finding supports these results that estrogen receptors are found in connective

tissue and thus, estrogen changes the mechanical properties of tendons and ligaments 12, 23.
In spite of that, researchers are still debating on the results of these studies because the
study methods and procedures were vastly different 22. However, female reproductive
hormones are more consistent during the menstrual cycle in women on the OCP. If knee
ligament laxity was affected by hormone fluctuation, female OCP users should show
more stable tissue extensibility.
Increased tissue temperature could be one factor that causes ligament and tendon
laxity and heat is commonly used to reduce soft tissue stiffness 25, 47. Basal body
tmeperature fluctuates duing the menstrual cycle in women, and this change is also
influenced by progesterone and estrogen 48, 49. Previous research found that muscle
temperature increased continuosly increased throughout the menstrual cycle and it
remaind elevated during the luteal phase 29, 31. Muscle temperature changed not just by
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one but by four to five degree in Celcious which is fairly significant changes temperature
in shell tissues during the menstral cycle 31. Muscle and shell tissue temperature
fluctuates during the menstraul cycle, thus temperature is also playing an important role
in knee elasticity. Therefore, in the present investigation, two series of experiments were
conducted to examine the relationship ACL elasticity, FFK, and KFEH during the
menstrual cycle. In series 1 (Chapter 2), we examined the relationship between estradiol
serum concentration and ACL elasticity, FFK, and KFEH and how this relates to tissue
temperature in young healthy women with a regular menstrual cycle. In series 2 (Chapter
3), we investigated the differences in ACL elasticity, FFK and KFEH between OCP users
and non-OCP users and its relationship to tissue temperature during the menstrual cycle.
The most important finding from series 1 was a significantly greater ACL
elasticity, less FFK, and KFEH during ovulation where estradiol serum concentration
peaks compared to the mensturation where estradiol level is lowest during the menstrual
cycle. Greater ACL elasticity was found to occur during ovulation. There are two factors
that may cause this: 1) estrogen and 2) tissue temperature. Ligaments must have more
elasticity with relatively higher temperature since these are elastic stuctures 42. In this
investigation, skin temperature was comparably lower during ovulation than menstruation
and the early follicular phase. But the only improtant temperature is the temperature of
deep tissue. There are very few papers on deep shell tissue temperature in deep tissues
during the menstrual cycle 31 . These investigations found that muscle temperature was
significantly elevated during ovulation and the well documented increase in core
temperature. This is because heat has to be conserved by skin to get increased body
temperature. Heat goes through the muscle and leaves the skin by radiation, convection,

61

conduction, and evaporation. Skin needs to be cooler than the core temperature to aid in
heat loss or conserve heat 34. Therefore, to keep the body cool at ovulation, the shell
needs to remove more heat; hence muscle temperature increases at ovulation.
When the knee was heated to 38 °C, there was still difference in ACL elasticity at
ovulation when compared to other phases of the menstrual cycle. Therefore, while the
temperature change in deep tissues causes increased laxness, so must estradiol. Both are
synergistic at ovulation in increasing ACL elasticity. However, previous studies
examining ACL elasticity did not control tissue temperature. Even regarding the
menstrual cycle, we go through large changes in shell temperature according to various
phases of the year. If studies were conducted on skiers, the results would have been
different from tennis players. Clothing and ambient temperature become important to
consider in also since this alters arm and leg temperature. This may be the reason the
results were so varied in different studies. No previous study has even had subjects
acclimatized to room temperature before measuring measurements.
This study also measured the FFK and KFEH in knee felxion and extension.
These measures examined muscle and tendon flexibility. Human muscles and tendons are
soft tissues composed of collagen fibers, which may be also affected by estradiol
concentration and temperature as explained above. Results of this sutdy showed a
significantly lower FFK and KFEH at ovulation compared to menstruation. This finding
indicates that less muscle and tendon stiffness are shown at ovulation than the
menstruation statge. In addition, this result may infer that less muscle flexibility occurs
with increased estradiol concentration and lower skin temperature which may lead to
higher muscle tissue temperautre in young healthy women. However, for the knee, the
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probable effect of estradiol is different. There was more energy storage at ovulation
showing increased laxity. When the leg was warmed to the core temperature, this effect
disappeared. This result implies that the flexibility is more affected by temperature than
estrogen; although estrogen is responsible for the temperature fluctuation. Thus, using
heat would be beneficial on increasing knee flexibility; the optimal time would be in the
menstruation and early follicular phase, where the less flexibility occurs.
Results from the series 2 study show that non-OCP users have a greater ACL
elasticity, less FFK, and KFEH in all phases compared to OCP users at ambient
temperature. We futher found that for non-OCP users’ biomechanical outcome
varaibales were altered throughout the mesntraul cycle, but not in OCP users during the
menstrual cycle. OCP users estradiol levels were much lower in all phases of the
menstrual cycle and did not alter during the menstrual cycle. These results imply that
estradiol serum concention has an impact on human ligament, muscle, and tendon. In
other words, more knee stiffness was found in women on OCP. Here estradiol was lower
in blood.
In addition, there were heat effects on muscle and tendon flexibility both in nonOCP and OCP uesers. The FFK and FFEH significantly decreased after 38 °C warming
of the leg in all phases in OCP users. In a similar manner, knee flexibility was
significantly reduced after using heat in all phases of the menstrual cycle except
ovulation, where estradiol serum concentration was relatively higher in non-OCP users.
These results imply that muscle and tendon flexibility is more affected by temperature
than estrogen. Interestingly, we found that FFK and FFEH decreased more after 38 °C
warming in OCP users compared to non-OCP users during the menstrual cycle. This
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indicated more effect of heat on FFK and KFEH in OCP users. Thus, using heat increases
knee flexibility in OCP users and is still beneficial to non-OCP users during menstruation
where estradiol levels are relatively low. However, for the ACL, the effects of estradiol
were different. The ADT did not significantly decrease after 38 °C warming in both
groups of subjects. Also, it was significantly higher during ovulation than menstruation
after heat.
However, as seen in this investigation, we did not examine how knee elasticity is
related to injuries. ACL elasticity and knee muscle and tendon flexibility may cause
injuries or may not. Temperature may be another factor that affects ACL injuries but
previous studies did not examine ACL elasticity under the same condition such as
controlling for the effects of clothing or environment temperature. Also, previous studies
have examined the association between ACL injuires and use of oral contraceptives 53,54.
However, results from these studies were perhaps inconclusive because these studies did
not examine the effect of both knee elasticity and tissue temperature. It is not easy to
examine the effects of OCP on ACL injuries only with ACL elasticity. Other factors
should be considered such as tissue temperature. Thus, in further investigation, both
estrogen and tissue temperature should be considered as key risk factors that can cause
ACL injuries during menstrual cycle in both OCP and non- OCP users.
In addition, interesitngly, it is common to do a warm up prior to exercise to
reduce injuries since less elasticity is related to tissue tears. However, in women, the
reverse seems to be true . Perhaps, the structure strength (e.g. collagen cross bridges) is
also altered by estrogen. This may explain differences in the results of some studies on
women versus men. These knee injuries may be caused by changes in collagen strength

64

not just elasticity. Estrogen may not only alter ACL elasticity, but may cause a change in
the breaking strength of the ACL. Just as bone can fracture due to glycogen crosslinking
even when it is dense, there may be a similar relationship with collagen in ligaments
whereby they may tear even if elastic. This would involve a shift in the force stress
curve for the ACL making the elastic region shorter and the plastic region larger due to
estrogen. There are no studies on structural strength of the ACL in relation to estrogen,
only elasticity. It will be interesting to see if there are collagen structure strength changes
during the menstrual cycle and its relationship to incidence of knee injuries in OCP users
and non-OCP users.
We indentified several limationas in the present investigation. Sample size of the
present study was small. Moreover, we only examined one full menstrual cycle.
Although we tested subjects enough times during the menstrual cycle, results may be
normalized if we examined more than one full menstrual cycle. Lastly, leg muscle
temperature should be taken in future studies instead of taking leg skin temperature. It
could be powerful evidence to support the relationship between estradiol serum
concentration and ACL elasticity, FFK, and KFEH and how this relates to tissue
temperature in young healthy women with a regular menstrual cycle.
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